In partnership with
You think 4x faster than you type. Your IDE should keep up.
Wispr Flow lets you dictate prompts, acceptance criteria, and bug reproductions inside Cursor or Warp — with automatic file name and variable recognition. Say user_id, get user_id. Say useEffect, get useEffect.
Paste directly into GitHub, Jira, or Linear. Give coding agents the full context they need without typing a novel.
89% of messages sent with zero edits. Millions of developers use Flow daily, including teams at OpenAI, Vercel, and Clay. Free on Mac, Windows, and iPhone.
Eli Lilly (LLY): The Pharmaceutical Powerhouse Entering a New Dimension
Eli Lilly and Company (LLY) has long been a cornerstone of the healthcare sector, but in recent years, it has transformed into a high-octane growth engine. Driven by its leadership in the GLP-1 space and a robust pipeline in oncology and neuroscience, LLY has moved from a steady dividend payer to a premier momentum stock. For technical analysts utilizing Elliott Wave theory, the current chart for LLY is a textbook example of a "super-cycle" in motion, where each corrective phase serves as a definitive launchpad for the next impulsive leg.
As we analyze the technical setup, LLY is currently navigating a pivotal transition point. The stock has successfully completed its initial major impulse and a constructive secondary correction, setting the stage for what appears to be a historic Wave 3 advance.
The Macro Impulse: Building the Foundation
The primary cycle we are tracking began at a major structural low of $623.00. This served as the origin point for Wave 1, which propelled the stock to a significant peak at $1,133.00.
Wave 1 Magnitude: This initial $510 move represented a fundamental re-rating of the company's valuation as the market priced in the massive success of its weight-loss and diabetes portfolio.
The Wave 2 Correction: Following the $1,133.00 peak, LLY entered a necessary Wave 2 corrective phase. This pullback found strong institutional support at the $850.00 level.
The Significance of $850: In Elliott Wave terms, this retracement successfully flushed out short-term speculative interest while maintaining the long-term bullish integrity of the stock. By holding the $850 floor, LLY established the critical "Point 3" for our Fibonacci extension projections.
The Fibonacci Roadmap: Projecting Wave 3
In Elliott Wave theory, Wave 3 is typically the longest and most powerful part of the sequence. It is where the "real money" is made, characterized by sustained institutional accumulation and gap-and-go price action. Using the $623 start, the $1,133 peak, and the $850 corrective low, we can identify three primary targets for this current impulsive leg.
1. The Initial Target: $1,675.18
This target is derived from the 1.618 x Wave 1 extension. Reaching $1,675 would represent a "standard" Wave 3 completion. Given LLY's current momentum and the expanding market for GLP-1 drugs, this level acts as the first major magnet for the price.
2. The Psychological Milestone: $1,870.00
This represents the 2.000 x Wave 1 extension. A move to $1,870 would signal that the current wave is becoming "extended," a common occurrence in sectors undergoing rapid technological or therapeutic disruption.
3. The "Super-Cycle" Target: $2,185.18
This is the 2.618 x Wave 1 extension. If LLY follows the trajectory of other high-growth tech and healthcare giants that have dominated their respective fields, $2,185 becomes the ultimate objective. Reaching this level would solidify LLY as one of the most valuable companies on the planet, reflecting a multi-trillion dollar market capitalization.
Claude is not just a chatbot anymore. Is your security team ready?
Claude.ai is one thing. Claude Cowork with MCP connections, running agentic workflows, taking actions across your data with ungoverned skills? That is a different conversation entirely, and most security teams are not equipped to govern it.
Harmonic Security is built to secure everything Claude offers. Full browser controls for Claude.ai, deep governance over agentic MCP workflows, and real-time visibility into what Claude is doing across your organization. So your CISO can say yes to the tools your business is already demanding.
Strategic Entry and Buy Points
For investors looking to participate in this Wave 3 advance, technical discipline is paramount. Based on the Wave 1 structure, two specific "Buy Points" have emerged as high-probability zones for accumulation:
The .786 Retracement ($1,023.86): This level served as a critical psychological barrier. Any consolidation near this mark during the early stages of Wave 3 offered a prime entry for swing traders.
The Wave 1 Peak ($1,133.00): This is the definitive "breakout" line. Once LLY cleared $1,133 with sustained volume, it confirmed the end of the Wave 2 correction and the formal commencement of the Wave 3 surge.
Summary of Key Technical Levels
Technical Event | Price Level | Note |
Wave 1 Origin | $623.00 | The base of the current cycle. |
Wave 2 Low | $850.00 | The definitive floor for the current advance. |
Current Pivot | $1,133.00 | The breakout trigger for Wave 3. |
Primary Target | $1,675.18 | The 1.618 Fibonacci extension objective. |
Secondary Target | $1,870.00 | The 2.000 Fibonacci extension objective. |
Extended Target | $2,185.18 | The 2.618 Fibonacci extension objective. |
The Fundamental Catalyst
Technical patterns rarely exist in a vacuum, and LLY's chart is backed by immense fundamental tailwinds. The company's dominance in the incretin market—specifically with Zepbound and Mounjaro—is creating a consistent revenue stream that supports these aggressive Fibonacci projections. Furthermore, LLY's success in Alzheimer's research and oncology provides a diversified growth profile that differentiates it from single-product biotech firms.
As the stock enters this Wave 3 phase, the market is no longer just valuing LLY as a "Big Pharma" company; it is valuing it as a platform technology company with a long runway for expansion.
Eli Lilly is currently in the "sweet spot" of its technical lifecycle. The successful defense of the $850 level during the Wave 2 correction was a massive win for the bulls, and the subsequent breakout above $1,133 has cleared the path for higher valuations.
While volatility is a natural part of any major advance, the mathematical projections toward $1,675 and eventually $2,185 provide a clear roadmap for the coming months and years. For those utilizing the Elliott Wave blueprint, the message is clear: the trend is established, the support is confirmed, and the most powerful part of the move is just beginning.
Accio Work: the AI Agent team that runs your business
Meet Accio Work—the agentic workspace for business owners and solopreneurs. Our smart agents handle sourcing, supplier negotiation, store management, and marketing on autopilot. Powered by Alibaba.com data, we turn ideas into action instantly. No setup, no hassle—just seamless execution while you stay in control and focus on growing your business.
Disclaimer: Technical analysis is based on historical price action and mathematical projections. Trading in equities involves significant risk. This article is for informational purposes and does not constitute financial advice.